ACOG Committee Opinion No. 427: Misoprostol for postabortion care.
The World Health Organization estimates that 67,000 women, mostly in developing countries, die each year from untreated or inadequately treated abortion complications. Postabortion care, a term commonly used by the international reproductive health community, refers to a specific set of services for women experiencing problems from all types of spontaneous or induced abortion. There is increasing evidence that misoprostol is a safe, effective, and acceptable method to achieve uterine evacuation for women needing postabortion care. To reduce maternal mortality, availability of postabortion care services must be increased. Misoprostol must be readily available especially for women who do not otherwise have access to postabortion care. Nurses and midwives can safely provide first-line postabortion care services, including in outpatient settings,provided they receive appropriate training and support. Access to contraception and safe abortion services prevents complications from unsafe abortion and decreases the need for postabortion care. It is much less expensive and far better for women's health to prevent the problem of unsafe abortion rather than to treat resulting complications.
D000027:Abortion, Incomplete / Q000188:drug therapy*; D005260:Female; D014943:Global Health; D006801:Humans; D008880:Midwifery; D016595:Misoprostol / Q000627:therapeutic use*; D009722:Nurse Practitioners; D010120:Oxytocics / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011247:Pregnancy
D010120:Oxytocics; D016595:Misoprostol